Cargando…
Therapeutic benefits of CD90‐negative cardiac stromal cells in rats with a 30‐day chronic infarct
Cardiac stromal cells (CSCs) can be derived from explant cultures, and a subgroup of these cells is viewed as cardiac mesenchymal stem cells due to their expression of CD90. Here, we sought to determine the therapeutic potential of CD90‐positive and CD90‐negative CSCs in a rat model of chronic myoca...
Autores principales: | Shen, Deliang, Shen, Miaoda, Liang, Hongxia, Tang, Junnan, Wang, Bo, Liu, Chuang, Wang, Peiwen, Dong, Jianzeng, Li, Ling, Zhang, Jinying, Caranasos, Thomas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824400/ https://www.ncbi.nlm.nih.gov/pubmed/29341439 http://dx.doi.org/10.1111/jcmm.13517 |
Ejemplares similares
-
Heart
Repair Using Nanogel-Encapsulated Human Cardiac
Stem Cells in Mice and Pigs with Myocardial Infarction
por: Tang, Junnan, et al.
Publicado: (2017) -
Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked With Cardiac Stem Cells in Heart Repair
por: Shen, Deliang, et al.
Publicado: (2016) -
Cardiac cell–integrated microneedle patch for treating myocardial infarction
por: Tang, Junnan, et al.
Publicado: (2018) -
Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction
por: Rymer, Jennifer A., et al.
Publicado: (2020) -
Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide
por: Vandergriff, Adam, et al.
Publicado: (2018)